Brief: Theradiag Reports Revenue Growth Of 9.7% In 2022

Theradiag SA

26/04/2023 06:41

April 26 (Reuters) - Theradiag SA  ALTHE.PA :
    * REVENUE GROWTH OF 9.7% IN 2022 DRIVEN BY DYNAMIC IVD AND
THERANOSTICS BUSINESSES
    * END-MARCH SOLID CASH POSITION AT €6.4 MILLION
    * Q1 SALES REACHED 3.3 MILLION EUROS, UP 6.1% COMPARED TO 
PREVIOUS YEAR
    * THE OBJECTIVE FOR 2023 IS TO DEVELOP A PROFITABLE AND
SUSTAINABLE GROWTH - CHAIRMAN
    * FY NET LOSS EUR 0.5 MILLION VERSUS LOSS EUR 0.8 MILLION
YEAR AGO
    * FY OPERATING LOSS EUR 0.3 MILLION VERSUS LOSS EUR 0.9
MILLION
YEAR AGO

Source text: https://bit.ly/3LsUXGn
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))